Fispemifene

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFispemifene
Drug Alias Name非培米芬fispemifenofispemifenumHM-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsHypogonadismErectile DysfunctionSexual Dysfunction, Physiological +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesQuatrx Pharmaceuticals Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNexmed (U.S.A.) IncQuatrx Pharmaceuticals Company
Active IndicationsN/A
Inactive IndicationsHypogonadismErectile DysfunctionSexual Dysfunction, Physiological +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG